Sign in
ARPO Stock Price, Chart, Stats & News
Aerpio Pharmaceuticals, Inc.
Save
53.67M
Market cap
–
Current P/E
–
Forward P/E
ARPO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | -1601.12% |
Pretax margin | -288.26% |
Net margin | -288.26% |
Effective tax rate | – |
ROA | -13.66% |
ROE | -11.99% |
D/E | – |
Interest coverage ratio | – |
ARPO valuation
P/E | – |
P/S | 7.51x |
P/B | 1.12x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -0.02x |
EV multiple | -0.81x |
About
Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-1536, also under development.
Similar securities
Based on sector and market capitalization
Report issue